It is well known that cancerous tumor cells have an acidic pH microenvironment (pH 5.6 to 6.8). Using this unique feature, researchers have developed a new anticancer therapeutic agent that selectively kills cancer cells. This access allows detached malignant cells from the tumor to penetrate into cancer cells and induce mitochondrial dysfunction, thereby killing only cancer cells.
